European Medicines Agency approves third dose of Pfizer vaccine for people over 18 years of age

The European Medicines Agency approved on Monday a third booster dose of the vaccine against COVID-19 by Pfizer / BioNTech for people over 18 years of age, concerned that protection will decrease after the first two injections.

“Comirnaty booster doses may be considered for people 18 years of age and older, at least six months after the second dose.”the EMA said in a statement, citing the brand name of the Pfizer vaccine.

News in development

• COVID-19 Treatments: What Works, What Doesn’t, and What’s in Proof
• COVID-19 | Booster shot has similar side effects to the second dose
• COVID-19 causes the biggest drop in life expectancy since World War II
• COVID-19 | Pfizer will request authorization to administer its vaccine to children between 5 and 12 years of age in the United States.
• COVID-19 | Pfizer booster dose increased antibody levels 20 times in Sinovac vaccinated
• Pfizer Starts Human Trials of Messenger RNA Flu Vaccine
• Delta Plus variant of coronavirus: More contagious and resistant to vaccines?

.

Deshawn